跳转至内容
Merck

272264

Sigma-Aldrich

1-(3-氨基丙基)咪唑

≥97%

别名:

1-(3-氨基丙基)咪唑, 3-(1-咪唑基)丙胺, 3-(1H-咪唑-1-基)丙胺, 3-(咪唑-1-基)丙胺, N-(3-氨基丙基)咪唑, N-[3-(1H-咪唑-1-基)丙基]胺

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C6H11N3
CAS号:
分子量:
125.17
EC號碼:
MDL號碼:
分類程式碼代碼:
12352005
PubChem物質ID:
NACRES:
NA.22

品質等級

化驗

≥97%

形狀

liquid

折射率

n20/D 1.519 (lit.)

密度

1.049 g/mL at 25 °C (lit.)

SMILES 字串

NCCCn1ccnc1

InChI

1S/C6H11N3/c7-2-1-4-9-5-3-8-6-9/h3,5-6H,1-2,4,7H2

InChI 密鑰

KDHWOCLBMVSZPG-UHFFFAOYSA-N

應用

1-(3-氨基丙基)咪唑被用于合成pH敏感性聚天冬酰胺衍生物。它还被用于通过接枝反应制备具有不同程度octaceylamine (C18)取代的pH敏感性两亲聚合物

象形圖

CorrosionExclamation mark

訊號詞

Danger

危險聲明

危險分類

Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Dam. 1 - Skin Corr. 1B

儲存類別代碼

8A - Combustible corrosive hazardous materials

水污染物質分類(WGK)

WGK 2

閃點(°F)

309.2 °F

閃點(°C)

154 °C

個人防護裝備

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Xiaodan Li et al.
Journal of controlled release : official journal of the Controlled Release Society, 260, 12-21 (2017-05-22)
Photodynamic therapy (PDT) efficacy is limited by the very short half-life and limited diffusion radius of singlet oxygen (
Abootaleb Sedighi et al.
Talanta, 186, 568-575 (2018-05-23)
Several solution-based methods have recently been adapted for use in paper substrates for enzymatic amplification to increase the number of copies of DNA sequences. There is limited information available about the impact of a paper matrix on DNA amplification by
Taehoon Sim et al.
Pharmaceutics, 12(9) (2020-09-06)
Combination therapy is considered to be a promising strategy for improving the therapeutic efficiency of cancer treatment. In this study, an on-demand pH-sensitive nanocluster (NC) system was prepared by the encapsulation of gold nanorods (AuNR) and doxorubicin (DOX) by a
Di Lu et al.
AAPS PharmSciTech (2018-06-20)
The complex design of multifunctional nanomedicine is beneficial to overcome the multiple biological barriers of drug delivery, but it also presents additional hurdles to clinical translation (e.g., scaling-up and quality control). To address this dilemma, we employed a simple imidazole-bearing
Kwangwon Seo et al.
Macromolecular bioscience, 6(9), 758-766 (2006-09-13)
New pH-sensitive polyaspartamide derivatives were synthesized by grafting 1-(3-aminopropyl)imidazole and/or O-(2-aminoethyl)-O'-methylpoly(ethylene glycol) 5000 on polysuccinimide for application in intracellular drug delivery systems. The DS of 1-(3-aminopropyl)imidazole was adjusted by the feed molar ratio, and the structure of the prepared polymer

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门